Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study. Attauabi M, Burisch J, Seidelin JB. Inflamm Bowel Dis 2020 Nov 17. pii: 5985019. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Attauabi M, Burisch J, Seidelin JB. Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study. Inflamm Bowel Dis 2020 Nov 17. pii: 5985019. doi: 10.1093.
PMID: 33200769